-Giuseppe Tonini Researcher Activity Profile

Research Author Detailed Information 

Giuseppe Tonini Publication Rate By Year

Giuseppe Tonini has published 6 paper(s) in 1959, 20 paper(s) in 2007, 17 paper(s) in 2008, for a total of 43 research publications in total.

Giuseppe G Tonini Author Information

LAST NAME: tonini

FIRST NAME: Giuseppe

INITIALS: g

AFFILIATION:

Papers

Giuseppe Tonini's Publication Record

1. Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan. Year Published: 2007
University Campus Bio-Medico, Medical Oncology, Via Emilio Longoni, 69, 00155, Rome, Italy. b.vincenzi@unicampus.it
2. Cetuximab: from biology to the care of colorectal cancer patients. Year Published: 2007
3. Occasional FDG PET recognition of in situ breast cancer. Year Published: 2007
4. Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma. Year Published: 2007
5. Cetuximab: from biology to the care of colorectal cancer patients. Year Published: 2007
6. A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid. Year Published: 2007
Department of Radiology, Centro Interdisciplinare per la Ricerca Bio-Medica, Via Longoni 47, 00155, Rome, Italy, c.quattrocchi@unicampus.it.
7. Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions. Year Published: 2007
8. The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE). Year Published: 2007
Medical Oncology Division B, National Cancer Institute, Naples, Italy.
9. Docetaxel induced pericardial effusion. Year Published: 2007
Medical Oncology, University Campus Bio-Medico, Rome, Italy. b.vincenzi@unicampus.it
10. Zoledronic Acid and angiogenesis. Year Published: 2007
Medical Oncology, University Campus Bio-Medico, Rome, Italy.
11. Molecular prognostic factors in patients with pancreatic cancer. Year Published: 2007
Campus Bio-Medico University, Medical Oncology, Via Emilio Longoni, 83, 00155, Rome, Italy. g.tonini@unicampus.it
12. Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. Year Published: 2007
Universita' di Palermo, Section of Medical Oncology, Department of Surgical and Oncological Sciences, Italy.
13. Occasional FDG PET recognition of in situ breast cancer. Year Published: 2007
14. The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE). Year Published: 2007
Medical Oncology Division B, National Cancer Institute, Naples, Italy.
15. Docetaxel induced pericardial effusion. Year Published: 2007
Medical Oncology, University Campus Bio-Medico, Rome, Italy. b.vincenzi@unicampus.it
16. Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. Year Published: 2008
Polytechnic University of Marche-Riuniti Hospital Umberto I-GM Lancisi-G Salesi of Ancona, 60020 Ancona, Italy.
17. Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. Year Published: 2008
Polytechnic University of Marche-Riuniti Hospital Umberto I-GM Lancisi-G Salesi of Ancona, 60020 Ancona, Italy. cascinu@yahoo.com
18. Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions. Year Published: 2008
University Campus Bio-Medico, Medical Oncology, Via Emilio Longoni, 83 00155 Rome, Italy +39 06 22541853 ; +39 06 22541520 ; g.tonini@unicampus.it.
19. Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs? Year Published: 2008
Medical Oncology, University Campus Bio-Medico, Rome. d.santini@unicampus.it
20. Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. Year Published: 2008
Polytechnic University of Marche-Riuniti Hospital Umberto I-GM Lancisi-G Salesi of Ancona, 60020 Ancona, Italy. cascinu@yahoo.com
21. Molecular prognostic factors in patients with pancreatic cancer. Year Published: 2007
Campus Bio-Medico University, Medical Oncology, Via Emilio Longoni, 83, 00155, Rome, Italy. g.tonini@unicampus.it
22. Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. Year Published: 2007
Universita' di Palermo, Section of Medical Oncology, Department of Surgical and Oncological Sciences, Italy.
23. Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report. Year Published: 2008
U.O.C. Oncologia, "S. Giovanni di Dio" Hospital, ASL Napoli3 Via Giovanni XXIII 80020 Frattaminore, Naples, Italy, lelloaddeo@alice.it.
24. [Pharmacological study of a series of alkylamine derivative substituted by dibenzoparathiazine. III. Some properties of a piperazine derivative.] Year Published: 1959
25. [Pharmacological research on a series of substituted alkylamine derivatives of dibenzoparathiazine. IV. Effects on the blood protein picture of the rat.] Year Published: 1959
26. [Pharmacological research on a series of substituted alkylamine derivatives of dibenzoparathiazine. V. Effects of prolonged treatment on blood glycoproteins.] Year Published: 1959
27. [Pharmacological data on a series of alkylamine-substituted derivatives of dibenzoparathiazine. I. Antagonism in regard to the central action of beta-phenylisopropylamine mixtures.] Year Published: 1959
28. [Pharmacological data on a series of alkylamine substituted derivatives of dibenzoparathiazine. II. Effect of basal metabolism in white rats.] Year Published: 1959
29. [Pharmacological research on a series of alkylamine-substituted derivatives of dibenzoparathizine. VI. Effects on the cerebral protein picture.] Year Published: 1959
30. Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions. Year Published: 2008
University Campus Bio-Medico, Medical Oncology, Via Emilio Longoni, 83 00155 Rome, Italy. g.tonini@unicampus.it
31. Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angio-genesis: A New Role for These Drugs? Year Published: 2008
Medical Oncology, University Campus Bio-Medico, Rome. d.santini@unicampus.it.
32. Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients. Year Published: 2007
Medical Oncolog, University Campus Bio-Medico, Rome, Italy. d.santini@unicampus.it
33. Cetuximab: from biology to the care of colorectal cancer patients. Year Published: 2007
34. A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid. Year Published: 2007
Department of Radiology, Centro Interdisciplinare per la Ricerca Bio-Medica, Via Longoni 47, 00155, Rome, Italy. c.quattrocchi@unicampus.it
35. Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions. Year Published: 2008
University Campus Bio-Medico, Medical Oncology, Via Emilio Longoni, 83 00155 Rome, Italy. g.tonini@unicampus.it
36. Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs? Year Published: 2008
Medical Oncology, University Campus Bio-Medico, Rome. d.santini@unicampus.it
37. Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer. Year Published: 2008
Department of Medical Oncology, University Campus Bio-Medico, via Emilio Longoni 81, 00155 Rome, Italy. d.santini@unicampus.it
38. Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer. Year Published: 2008
Medical Oncology Unit, Hospital of Pesaro, Pesaro, Italy. frada@tin.it
39. Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease. Year Published: 2008
Department of Orthopaedics and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy.
40. Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer. Year Published: 2008
Department of Pharmacology, University of Florence, Florence, Italy.
41. Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report. Year Published: 2008
UOC Oncologia, S Giovanni di Dio Hospital, ASL Napoli3 Via Giovanni XXIII 80020 Frattaminore, Naples, Italy. lelloaddeo@alice.it
42. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Year Published: 2008
Italian Auxological Institute Foundation, Research Institute, Verbania, Italy. g.grugni@auxologico.it
43. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Year Published: 2008
Italian Auxological Institute Foundation, Research Institute, Verbania, Italy. g.grugni@auxologico.it